Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

The attainment of life goals by adult survivors of childhood cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This ...

In a recent review published in the Microorganisms Journal, researchers reviewed existing data on the use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria, ...

Antimicrobials with the potential to act as immune stimulators and overcome bacterial resistance are emerging as important alternative approaches to fighting antimicrobial resistance The novel ...

Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected with it each year, and ...

A researcher team is collaborating with a Belgian industry partner to develop an antibody-based rapid VRE test capable of reliably detecting the expression of VanA and VanB. Enterococcus faecium is a ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

Researchers have developed small molecules to combat deadly, drug-resistant enterococcus. Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the ...

A drug-resistant strain of bacteria inhabiting hospital settings has evolved to utilize an antimicrobial genetic tool. Vancomycin-resistant Enterococcus faecium (VREfm) is responsible for many lethal ...